214 research outputs found

    Supplemental material for Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension

    No full text
    Supplemental Material for Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension by Catherine E. Simpson, Rachel L. Damico, Laura Hummers, Rubina M. Khair, Todd M. Kolb, Paul M. Hassoun and Stephen C. Mathai in Pulmonary Circulation</p

    sj-docx-1-ajr-10.1177_19458924231207123 - Supplemental material for Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review

    No full text
    Supplemental material, sj-docx-1-ajr-10.1177_19458924231207123 for Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review by Anna J. Gong, Tushar Garg, Adham Khalil, Prateek C. Gowda, Stephen C. Mathai, Nicholas R. Rowan, Christian A. Merlo and Clifford R. Weiss in American Journal of Rhinology & Allergy</p

    Dynamics of finite-sized light spheres in turbulence

    No full text
    We report experimental results on the Lagrangian dynamics of finite-size light particles in turbulence. Using an orthogonal camera setup and 3D particle tracking, we study the velocity and acceleration statistics of rigid light spheres in a water tunnel with nearly homogeneous and isotropic turbulence. The Reynolds number (ReY) is varied from 180 to 300, and the study covers a range of size ratios (4 < D/η < 16) for marginally light spheres. We find that the normalised acceleration PDF decreases in intermittency with increasing size ratio - in qualitative agreement with the predictions of the Faxén corrected model. We also present preliminary results on the rotational dynamics of large light spheres in turbulence

    sj-pdf-1-pul-10.1177_20458940211032529 - Supplemental material for Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements

    No full text
    Supplemental material, sj-pdf-1-pul-10.1177_20458940211032529 for Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements by Takahiro Sato, Bharath Ambale-Venkatesh, Stefan L. Zimmerman, Ryan J. Tedford, Steven Hsu, Ela Chamera, Tomoki Fujii, Christopher J. Mullin, Valentina Mercurio, Rubina Khair, Celia P. Corona-Villalobos, Catherine E. Simpson, Rachel L. Damico, Todd M. Kolb, Stephen C. Mathai, Joao A.C. Lima, David A. Kass, Ichizo Tsujino and Paul M. Hassoun in Pulmonary Circulation</p

    Supplemental material for The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study

    No full text
    Supplemental material, for The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study by Takahiro Sato, Bharath Ambale-Venkatesh, Joao A.C. Lima, Stefan L. Zimmerman, Ryan J. Tedford, Tomoki Fujii, Olivia L. Hulme, Erica H. Pullins, Celia P. Corona-Villalobos, Roham T. Zamanian, Omar A. Minai, Reda E. Girgis, Kelly Chin, Rubina Khair, Rachel L. Damico, Todd M. Kolb, Stephen C. Mathai, Paul M. Hassoun in Pulmonary Circulation</p

    sj-pdf-2-pul-10.1177_20458940211032529 - Supplemental material for Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements

    No full text
    Supplemental material, sj-pdf-2-pul-10.1177_20458940211032529 for Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements by Takahiro Sato, Bharath Ambale-Venkatesh, Stefan L. Zimmerman, Ryan J. Tedford, Steven Hsu, Ela Chamera, Tomoki Fujii, Christopher J. Mullin, Valentina Mercurio, Rubina Khair, Celia P. Corona-Villalobos, Catherine E. Simpson, Rachel L. Damico, Todd M. Kolb, Stephen C. Mathai, Joao A.C. Lima, David A. Kass, Ichizo Tsujino and Paul M. Hassoun in Pulmonary Circulation</p

    Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction

    No full text
    Pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) has been poorly studied in patients with systemic sclerosis (SSc). We sought to compare clinical characteristics and survival of SSc patients with PH-HFpEF (SSc-PH-HFpEF) versus pulmonary arterial hypertension (SSc-PAH). We hypothesized that patients with SSc-PH-HFpEF have a similar poor overall prognosis compared with patients with SSc-PAH when matched for total right ventricular load. The analysis included 117 patients with SSc-PH (93 with SSc-PAH versus 24 with SSc-PH-HFpEF) enrolled prospectively in the Johns Hopkins PH Registry. We examined baseline demographics and hemodynamics at diagnostic right heart catheterization (RHC), two-dimensional echocardiographic characteristics, six-minute walking distance (6MWD), treatment modalities, and laboratory values (serum NT-proBNP, creatinine, uric acid, and sodium), and assessed survival. Demographics and clinical features were similar between the two groups. Baseline RHC showed significantly higher pulmonary and right heart pressures in the SSc-PH-HFpEF compared with the SSc-PAH group. Trans-pulmonary gradient (TPG), however, was equally elevated without significant difference between the groups. SSc-PH-HFpEF patients had left atrial enlargement on echocardiography compared with SSc-PAH patients. No significant differences were found between groups for 6MWD, NT-proBNP, and other laboratory values. Although overall median survival time was 4.6 years with no difference in mortality rate between the two groups (SSc-PH-HFpEF versus SSc-PAH: 75% versus 59%; P = 0.26), patients with SSc-PH-HFpEF had a twofold increased risk of death compared with SSc-PAH patients after adjusting for hemodynamics. Concomitant intrinsic pulmonary vascular disease and HFpEF likely contribute to very poor survival in patients with SSc-PH-HFpEF

    Thom form in equivariant Cech-de Rham theory

    Get PDF
    In the present paper, we provide the foundation of a G-equivariant Cechde Rham theory for a compact Lie group G by using the Cartan model of equivariant differential forms. Our approach is quite elementary without referring to the Mathai Quillen framework. In particular, by a direct computation, we give an explicit formula of the U(l)-equivariant Thom form of C-l, which deforms the classical BochnorMartinelli kernel. Also, we discuss a version of equivariant RiemannRoch formula

    Sofic groups and diophantine approximation

    No full text
    We prove the algebraic eigenvalue conjecture of J. Dodziuk, P. Linnell, V. Mathai, T. Schick, and S. Yates (see [2]) for sofic groups. Moreover, we give restrictions on the spectral measure of elements in the integral group ring. Finally, we define integer operators and prove a quantization of the operator norm below 2. To the knowledge of the author, there is no group known that is not sofic. (c) 2007 Wiley Periodicals, Inc
    corecore